Drugs Made In America Acq... (DMAA)
NASDAQ: DMAA
· Real-Time Price · USD
10.27
-0.01 (-0.10%)
At close: Aug 15, 2025, 3:56 PM
10.27
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
Drugs Made In America Acquisition Ordinary Shares Revenue
Drugs Made In America Acquisition Ordinary Shares reported an annual revenue of $0, reflecting a undefined% growth. For the quarter ending March 31, 2025, Drugs Made In America Acquisition Ordinary Shares generated $0 in revenue.
Revenue (ttm)
n/a
Revenue Growth
n/a
Price / Sales Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
344.22M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|